|

DP303c Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2

Indications

  • Cancer2
  • HER2-positive Breast Cancer1
  • Advanced Solid Tumors1
  • Breast Cancer1

Other2 trials

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
Phase 1/2
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.